Baseline characteristic of participants
| N=30 | |
|---|---|
| Age, years | 64.1 ± 9.9 |
| Diabetes mellitus | 2 (7%) |
| Hypertension | 10 (33%) |
| Dyslipidaemia | 4 (13%) |
| Smoking history | 3 (10%) |
| History of coronary disease | 1 (3%) |
| Chemotherapy | |
| Anthracycline-based therapy | 15 (50%) |
| Docetaxel/Paclitaxel | 14 (47%) |
| Cyclophosphamide | 18 (60%) |
| Carboplatin | 3 (10%) |